Introduction
The crossover design, which compares two treatments over two periods, has held a dominant position in the application of crossover designs to the extent that -in the majority of articles and texts -it is referred to as the crossover design. Crossover designs are popular for comparing several non-curative treatments for their efficacy. For convenience, a crossover design with t treatments, p periods and s sequences is denoted as a C (t, p, s).
Critiques of the C (2, 2, 2) with sequences AB and BA are well known; the most serious of these is that the carryover effect is confounded with sequence by period effects leading to erroneous analyses. To overcome the disadvantages of the C (2, 2, 2), a higher-order crossover design may be used. Two strategies can be employed to overcome the problems James F. Reed III, Ph.D., is the Director, Clinical Business Intelligence Biostatistician, Adventist Health. Email him at: ReedJF@ah.org. inherent in the C (2, 2, 2) design. The first strategy is to extend the number of sequences, such as Balaam's C (2, 2, 4) design (Balaam, 1968) ; this design has four sequences, AA|AB|BA|BB. In addition, unbiased estimates of treatment and carryover effect can be formulated using a strategy outlined by Matthews (Matthews, 1994; Laska, Meisner & Kushner, 1983; Reed, 2010) . The second strategy is to extend the classic design by adding a third period and/or a fourth period and repeating one of the two treatments.
Higher-order four period crossover designs with two treatments can result in sixteen possible treatment sequences: AAAA, AAAB, AABA, AABB, ABAA, ABAB, ABBA, ABBB and their duals. This article considers four designs: Design I: ABBA and its dual; Design II: ABBA, AABB and their duals, Design III: ABBA, ABAA and their duals, Design IV: ABBA, ABAB and their duals. This article presents methods for estimating treatment and first-order carryover effects in the set of four period trials, assuming a traditional model that specifies a first-order carryover effect.
Crossover Design Model with Continuous Data
Assume that the primary goal is to compare two treatments A and B used in a study by estimating the treatment contrast τ A -τ B and period effects π 1 and π 2 ; first order carryover effects λ A , λ B and μ are regarded as nuisance parameters. Also assume that the response variable is continuous and that there is one response from each subject in each period. Finally, it is assumed that each treatment has a simple first-order carryover effect that does not interact with the direct effect of the treatment in the subsequent period. This model then assumes the following for the response of patient y ij .
If y ijk denotes the observed response of subject j (j = 1, …, n) in period i (i = 1, …, p), then
is the simple first-order carryover effect of treatment D, and d(i,j) is the treatment allocated to patient j in period i. λ d(0,j) = 0 for all j. It is assumed that all effects are fixed effects. β j is the effect of patient j and ε ij is the error term. The random subject effect, β j , and the experimental error, ε ij , are assumed to be mutually independently distributed as N (0, σ 2 β ) and N (0, σ 2 ε ).
Design I: ABBA and Its Dual
An optimal two-sequence three period crossover design is the ABB/BAA design (Laska & Meisner, 1985; Hedayat & Stufken, 2003) . This design is sometimes referred to as the twosequence dual design because it allows an estimate of both treatment and carryover effect. The first design considered extends this by adding a fourth period and considering the sequence ABBA and its dual (see Table 1 ).
In sequence ABBA, the contrast, c 1 = y 11 + 2y 12 + y 13 + y 14 has expectation 5μ + (π 1 + 2 π 2 + π 3 + π 4 ) + (2τ A +3 τ B ) + (2λ A +2 λ B ). In sequence BAAB, the contrast c 2 = y 21 + 2y 22 + y 32 -y 42 has expectation 5μ + (π 1 + 2 π 2 + π 3 + π 4 ) + (2τ B +3 τ A ) + (2λ A +2 λ B ). The difference between contrast c 1 and c 2 forms an unbiased estimator of τ A − τ B . For the construction of an unbiased estimator of any carryover effect, λ A -λ B , consider c 3 = y 11 -y 12 + y 13 -y 14 and c 4 = y 21 − y 22 + y 32 -y 42 . The difference between c 3 and c 4 forms an unbiased estimate of λ A − λ B . Note that if the last period is omitted, this design reduces to an optimal two-sequence dual design. If the last two periods are eliminated, the design becomes the standard AB/BA crossover design.
Design II: ABBA, AABB and Their Duals This four-sequence, four-period design is a combination of two Balaam designs. The first two periods are the same as Balaam's design, while periods 3 and 4 are copies of Balaam's design reversed (see Table 2 ).
In sequence ABBA, the contrast c 1 = y 11 + y 12 − y 13 + y 14 has expectation 2μ + (π 1 + π 2 -π 3 + π 4 ) + (2τ A +λ A ). In AABB, the contrast c 2 = y 21 + y 22 -y 23 − y 24 has expectation 2μ + (π 1 + 2 π 2 − π 3 + π 4 ) + (2τ A + λ B ). In sequence BAAB, the contrast c 3 = y 31 + y 32 − y 33 − y 34 has expectation 2μ + (π 1 + 2 π 2 − π 3 + π 4 ) + (2τ B + λ B ), and in BBAA the contrast c 4 = y 41 + y 22 − y 43 − y 44 has expectation 2μ + (π 1 + 2 π 2 − π 3 + π 4 ) + (2τ B + λ A ). A combination of (c 1 − c 4 ) + (c 2 − c 3 ) forms an unbiased estimate of treatment effect (τ A − τ B ).
In Table 3 Table 4 ). 
Discussion
This article considered four two-treatment in four-period crossover designs. For a simple one period carryover effect model, the four designs presented are ideal because the design efficiencies are optimal. The designs with the highest efficiency (100%) are the AABB, ABBA and their duals ( Table 2 ). The other designs considered weigh in at 91% (Hedayat & Stufken, 2003) . All designs are robust, simple and easily implemented.
Higher-order crossover designs are useful because they allow a treatment effect to be estimated even in the presence of a carry-over effect, they provide estimates of intra-subject variability and they draw inference on the carryover effect (Chow & Lu, 1992) . Are these fourperiod crossover designs useful? Perhaps. The true question relates to the application of these designs.
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